Buscador de Publicaciones

Differences in cancer drug assessment between Spain and the United Kingdom

Autores: Lozano-Blazquez, A; Dickson, R; Fraga-Fuentes, MD; Martinez-Martinez, F; Calleja-Hernandez, MA

Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients

Autores: Perez-Ramirez, C; Canadas-Garre, M; Alnatsha, A; Villar, E; Delgado, JR; Faus-Dader, MJ; Calleja-Hernandez, MA

ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients

Autores: Madrid-Paredes, A; Canadas-Garre, M; Sanchez-Pozo, A; Segura-Perez, AM; Chamorro-Santos, C; Vergara-Alcaide, E; Castillo-Portellano, L; Calleja-Hernandez, MA

Medication-related negative outcomes in patients with permanent atrial fibrillation attended in a hospital emergency department

Autores: Torres-Degayon, V; Montero-Perez, FJ; Torres-Murillo, JM; Faus-Dader, MJ; Baena-Parejo, MI; Calleja-Hernandez, MA

Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer

Autores: Fernandez-Lopez, C; Exposito-Hernandez, J; Arrebola-Moreno, JP; Calleja-Hernandez, MA; Exposito-Ruiz, M; Guerrero-Tejada, R; Linares, I; Cabeza-Barrera, J

Patient safety: The pharmacist’s contribution to a multidisciplinary Internal Medicine patient-care team

Autores: Allende-Bandres, MA; Ruiz-Laiglesia, FJ; Gutierrez-Nicolas, F; Hernandez, MAC

Reliability and external validity of a questionnaire to assess the knowledge about risk and cardiovascular disease and in patients attending Spanish community pharmacies

Autores: Amariles, P; Pino-Marin, D; Sabater-Hernandez, D; Garcia-Jimenez, E; Roig-Sanchez, I; Faus, MJ

< 1 2 … 1.049 1.050 1.051 … 1.504 1.505 >